Friday, October 26, 2018 9:07:26 AM
What does this Miss Primary end points mean for $RARE?
https://finance.yahoo.com/news/ultragenyx-announces-negative-topline-results-120000119.html
https://finance.yahoo.com/news/ultragenyx-announces-negative-topline-results-120000119.html
Recent RARE News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 10:41:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 10:39:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 10:38:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/18/2026 08:50:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 06:15:14 PM
- Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference • GlobeNewswire Inc. • 05/06/2026 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 06:51:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:06:15 PM
- Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update • GlobeNewswire Inc. • 05/05/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 09:35:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2026 08:06:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/30/2026 08:04:21 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 07:48:02 PM
- Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update • GlobeNewswire Inc. • 04/29/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 08:39:40 PM
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/24/2026 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 09:17:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 09:13:09 PM
- Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE • PR Newswire (US) • 04/06/2026 06:24:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:19:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:45:09 PM
- Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 08:12:33 PM
- RARE Shareholder Alert: Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:45:08 PM
